Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Growing Pains for Generic Drugs: OGD Gains Respect, But Loses Geba

Mar 21 2013

• By Kate Rawson

Related Content

FDA's Generic Drugs Office Faces Transition As Director Buehler Departs

Mar 08 2010

FDA’s Latest PR Push: Protecting the Reputation of Generic Drugs

Apr 09 2012

FDA Generics Office Gets Third Director In Three Workdays; Uhl Brings Policy, Pharmacology Experience

Mar 20 2013

Getting Organized for GDUFA: FDA Elevates Generic Review Activities Under New Director Geba

Sep 10 2012

GDUFA Launch Pains: Facility List Fluctuations, Back-Due Backlog Fees

Feb 18 2013

Related Companies

Teva Pharmaceutical Industries Ltd.

Viatris Inc.

GSK plc

Additional Topics

United States Regulation Approvals Leadership BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window